Showing results (51-60 of 501) with videos related to
Sort By:
Pageof 51
Radiation Oncology (London, England)|August 3, 2012
The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancerJure Murgic, Matthew H Stenmark, Schuyler Halverson, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 29, 2007
Sonography of wrist ganglion cysts: variable and noncystic appearancesGeorge Wang, Jon A Jacobson, Felix Y Feng, et al.International Journal of Radiation Oncology, Biology, Physics|February 25, 2011
The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapyYushen Qian, Felix Y Feng, Schuyler Halverson, et al.Proceedings of the National Academy of Sciences of the United States of America|December 20, 2012
Defining principles of combination drug mechanisms of actionJustin R Pritchard, Peter M Bruno, Luke A Gilbert, et al.Proceedings of the National Academy of Sciences of the United States of America|June 22, 2016
Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbationChristian J Braun, Peter M Bruno, Max A Horlbeck, et al.Bioorganic & Medicinal Chemistry|October 17, 2020
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cellsJames E Melnyk, Veronica Steri, Hao G Nguyen, et al.American Journal of Clinical Oncology|February 4, 2014
Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation TherapyJeffrey M Vainshtein, Matthew Schipper, Sean Vance, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 16, 2020
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment DecisionsRana R McKay, Felix Y Feng, Alice Y Wang, et al.International Journal of Radiation Oncology, Biology, Physics|June 8, 2011
Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk diseaseMatthew H Stenmark, Kevin Blas, Schuyler Halverson, et al.International Journal of Radiation Oncology, Biology, Physics|November 8, 2011
Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapySean M Vance, Matthew H Stenmark, Kevin Blas, et al.Pageof 51